Cargando…
A HER2‐targeted Antibody‐Drug Conjugate, RC48‐ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer
More than half of non‐muscle‐invasive bladder cancer (NMIBC) patients eventually relapse even if treated with surgery and BCG without optional bladder‐preserving therapy. This study aims to investigate the antitumor activity and safety of a HER2‐targeted antibody‐drug conjugate, RC48‐ADC, intravesic...
Autores principales: | Hong, Xuwei, Chen, Xu, Wang, Hongjin, Xu, Qingchun, Xiao, Kanghua, Zhang, Yuanfeng, Chi, Zepai, Liu, Yeqing, Liu, Guangyao, Li, Hong, Fang, Jianmin, Lin, Tianxin, Zhang, Yonghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646285/ https://www.ncbi.nlm.nih.gov/pubmed/37824205 http://dx.doi.org/10.1002/advs.202302377 |
Ejemplares similares
-
Influencing factors for mortality in prostate cancer patients with T1 and T2 stage: a retrospective cohort study
por: Hong, Xuwei, et al.
Publicado: (2023) -
From AVATAR Mice to Patients: RC48-ADC Exerted Promising Efficacy in Advanced Gastric Cancer With HER2 Expression
por: Chen, Zuhua, et al.
Publicado: (2022) -
Construction of 3D and 2D contrast-enhanced CT radiomics for prediction of CGB3 expression level and clinical prognosis in bladder cancer
por: Zhang, Yuanfeng, et al.
Publicado: (2023) -
Predictive model for urosepsis in patients with Upper Urinary Tract Calculi based on ultrasonography and urinalysis using artificial intelligence learning
por: Hong, Xuwei, et al.
Publicado: (2022) -
Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
por: Wu, Weichu, et al.
Publicado: (2023)